Astellas Pharma logo

Astellas Pharma

ALPMY | OTC
Chart Builder DCF Calculator
$16.95
+$0.11 (+0.62%)
At close: Nov 16, 2026, 3:58 PM ET
$16.95
$0.00 (0.00%)
After-hours: Nov 16, 2026, 3:58 PM ET
+0.62%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
72.7
-0.9 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #40/1021 (Top 4%)

Key Statistics

Market Data

Market Cap $30.39B
1D Range
16.95 17.20
52W Range
12.14 17.20

Valuation (TTM)

PE 12.43
PB 2.41
EV/EBITDA 6.72

Valuation (NTM)

Forward PE 12.44
Forward PEG 0.34
Price Target $0.00
Loading financial charts...

Profile

Astellas Pharma Inc. operates as a global pharmaceutical enterprise, specializing in the research, development, manufacturing, and commercialization of a broad spectrum of medicinal products worldwide...

Sector Healthcare
Employees 14,099
IPO Date Dec 29, 2009
Fiscal Year April - March

Latest News

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

13 days ago · zacks.com

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?
Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?

29 days ago · zacks.com

Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers

3 months ago · zacks.com

Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
New Strong Sell Stocks for August 19th

3 months ago · zacks.com

New Strong Sell Stocks for August 19th
Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors

3 months ago · seekingalpha.com

Impax International Sustainable Economy Fund Q2 2026 Contributors And Detractors
New Strong Sell Stocks for August 6th

3 months ago · zacks.com

New Strong Sell Stocks for August 6th
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?

5 months ago · zacks.com

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?

5 months ago · zacks.com

Is Astellas Pharma (ALPMY) Stock Undervalued Right Now?

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.35
Miss -14.88%
REV
$3.99B
Beat +5.32%
Next Earnings
Feb 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.